Drug intelligence / Profile preview

Artelac Lipids

Development stage
Unknown
Lead developer
Bausch + Lomb
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Ophthalmic
01

Overview

Artelac Lipids is an ophthalmic lubricant formulated to relieve symptoms of chronic tear dysfunction and dry eye disease. It is designed to support all three layers of the tear film by providing hydration with sterile water, moisture retention with carbomer, and stabilization of the lipid layer using medium chain triglycerides. This combination helps reduce evaporation from the ocular surface and provides long-lasting relief for patients experiencing burning, gritty sensation, blurry vision, or excessive tearing due to dry eyes. The product is preservative-free in some presentations and suitable for individuals with persistent or severe dry eye symptoms caused by chronic conditions or medication use. Its mechanism of action involves supplementing both the aqueous and lipid components of the natural tear film to restore ocular surface homeostasis[1][3][4][5][7].

Brand names
Artelac Lipids
Other names
Artelac LipidsArtelac Lipids MD eye gel

Beyond the preview

Go deeper on Artelac Lipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artelac Lipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call